Rankings
▼
Calendar
LAB Q4 2016 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena
LAB
Standard BioTools Inc.
$370M
Q4 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$25M
Gross Profit
$14M
55.2% margin
Operating Income
-$18M
-70.6% margin
Net Income
-$18M
-70.6% margin
EPS (Diluted)
$-0.61
QoQ Revenue Growth
+13.0%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$306M
Total Liabilities
$253M
Stockholders' Equity
$53M
Cash & Equivalents
$35M
Geographic Segments
CHINA
$3M
100%
← FY 2016
All Quarters
Q1 2017 →